In a significant advancement for Alzheimer’s treatment, the U.S. Food and Drug Administration (FDA) has approved Eisai and Biogen’s...
Read MoreOn 24 January 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved garadacimab, marketed under the brand name...
Read MoreIn a groundbreaking development for medical science, the INTERCEPT project has launched Europe’s first biomarker trial aimed at preventing...
Read MoreTris Pharma, Inc. has announced highly encouraging results from its ALLEVIATE-1 phase 3 clinical trial evaluating cebranopadol as a...
Read MoreCambridge Cognition Holdings plc has announced an expansion of its partnership with Actinogen Medical Limited, reinforcing its support for...
Read MoreOxford Drug Design, an innovative drug discovery company based in Oxford, has announced promising new results in the development...
Read More